Evidence that GlaxoSmithKline concealed adverse events in their trial testing their diabetes drug, Avandia, raises the question “whether the entire system is corrupt.” “To the extent that we can’t trust the data. We are in jeopardy of giving patients the wrong drugs.” Dr. Jerome Kassirer
A large-scale Harvard meta-analysis published in the Journal of the American Medical Association, is the first ever to evaluate the relationship between different anticonvulsant drugs and the risk of suicide in for patients with diverse diagnoses: " the risk was derived from the specific drug that the patient was taking and not their underlying conditions."
"For her last month of life, Kifuji overall prescribed 835 pills to Rebecca….If what Dr. Kifuji did in this case is the acceptable standard of care for children in Massachusetts, then there is something very wrong in this state."
Why Has Columbia Expended So Much Effort to Avoid the Conclusion of Patient Harm?
The Alliance for Human Research Protection (AHRP) has recently obtained further information reaffirming our original concerns and raising new ones about the safety and ethics of a government sponsored clinical trial.
AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.
The comments below expand upon an Infomail about the recently published JAMA meta-analysis.
The system has provided companies an opportunity to make spectacular profits from the widespread use of defective drugs and vaccines that have caused irreversible harm.
Until now, American medicine as a profession has turned a blind eye and deaf ear to ghostwritten journal articles that have corrupted the integrity of the medical literature, displacing science-based medicine with corporate propaganda masquerading as science.
Sen. Charles Grassley’s focused investigation is clearly aimed at cleansing fraudulent, industry-crafted promotional pieces that have made a mockery of evidence-based clinical practice in psychiatry.
The Institute of Medicine has issued a “scolding,” “stinging,” and “damning” report about financial conflicts of interest in American medicine involving pharmaceutical, medical device, and biotechnology companies.
The FDA is sliding rapidly down the slippery slope, abandoning widely accepted, international ethical research standards articulated in the internationally accepted, Declaration of Helsinki–to facilitate commercial medical experiments.
